Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
Part of paid clinical trials in Richmond, Virginia.
- Sponsor
- Hunter Holmes Mcguire Veteran Affairs Medical Center
- Study ID
- NCT06052176
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Cirrhosis
- Hepatic Encephalopathy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Albumin Infusion — DRUGIntravenous human serum albumin to be given at 1.5g/kg ideal body weight
Study Details
Hypothesis: Improvement in cognitive dysfunction with IV albumin in patients with cirrhosis with prior HE and MHE lasts for several weeks after albumin infusion has ended, and is due to persistent improvement in inflammatory markers, endothelial dysfunction, albumin function and gut microbial changes. This will be a single-arm, single-blind sequential trial of IV 25% albumin and IV saline over 8 weeks with biological sampling and cognitive and health related quality of life (HRQOL) testing with each subject acting as their own control.
Key Dates
- Start date
- Nov 2, 2023
- Status verified
- Apr 2026
- Primary completion
- Oct 1, 2026
- Completion
- Dec 1, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- PREVENTION
Arms
- Placebo Comparator: PlaceboSaline given at the same volume as the albumin on visits the patients are assigned to it
- Active Comparator: AlbuminIV Albumin at 1.5g/kg ideal body weight
Primary Outcome Measure
Delta change in Psychometric Hepatic Encephalopathy Score (PHES) in Placebo phase vs Albumin phase [ Time Frame: 4 weeks each ]
Central Contacts
- Jasmohan Bajaj, MD8046755802
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hunter Holmes McGuire VA Medical Center | Richmond | Virginia | 23249 | Jasmohan S Bajaj, MD, MSc (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Richmond, VA
By research site
Related Studies
- Intestinal Microbiota Transplant in Alcohol-Associated Liver DiseasePHASE1/PHASE2 · Recruiting · Virginia Commonwealth University · Richmond, Virginia
- Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesPHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · La Jolla, California
- A Prospective Study of Memantine in Patients With Cirrhosis and Liver CancerPHASE2/PHASE3 · Recruiting · Inova Health Care Services · Fairfax, Virginia
- Microbiome Modulation With Prebiotics in PTSD and CirrhosisRecruiting · Hunter Holmes Mcguire Veteran Affairs Medical Center · Richmond, Virginia